ARCHIVES

NCI Director Andrew von Eschenbach To Resign June 10, Remain As FDA Acting Commissioner.

This article is from The Cancer Letter archive.

Vol. 32 No. 21 | June 2, 2006

Download PDF Visit The Full Archive

Related Articles

In Brief : Three Named To Leadership Posts At St. Jude; Mitchell Weiss Appointed Chair of Hematology

July 11, 2014

SSO Education Group Lists “Major Unmet Needs, Problems”

November 25, 1983

NCI Research Project Grant Funding To Exceed $1 Billion In Fiscal 1997

March 14, 1997

Drug Combination Tested For B.C. Brain Metastases

January 25, 2008

ACS Defends Dialogue, Calls Story “Misleading”.

October 20, 2000

Minimally Invasive Surgery Results In Lower Mortality Rate For Esophageal Removal

April 25, 2003